By G HossainPosted on September 22, 2026Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs With sales of the oral GLP-1 medicine rising quickly, executives reassured investors that Novo has secured production capacity to support continued growth. Novo targets 10-fold jump in oral Wegovy manufacturing capacity by 2030 Post navigation 2026 IPO blitz continues with 4 new biotech filingsOpen Tax Technology Alliance launches with free 1040 engine
